Annual Working Capital
-$7.80 M
-$15.53 M-201.07%
December 31, 2023
Summary
- As of March 10, 2025, INKT annual working capital is -$7.80 million, with the most recent change of -$15.53 million (-201.07%) on December 31, 2023.
- During the last 3 years, INKT annual working capital has risen by +$2.32 million (+22.92%).
- INKT annual working capital is now -133.68% below its all-time high of $23.17 million, reached on December 31, 2021.
Performance
INKT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$823.80 K
-$150.00 K-22.26%
September 30, 2024
Summary
- As of March 10, 2025, INKT quarterly working capital is -$823.80 thousand, with the most recent change of -$150.00 thousand (-22.26%) on September 30, 2024.
- Over the past year, INKT quarterly working capital has stayed the same.
- INKT quarterly working capital is now -103.56% below its all-time high of $23.17 million, reached on December 31, 2021.
Performance
INKT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
INKT Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -201.1% | 0.0% |
| 3 y3 years | +22.9% | 0.0% |
| 5 y5 years | -20.1% | 0.0% |
INKT Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -133.7% | at low | -103.6% | +89.4% |
| 5 y | 5-year | -133.7% | +22.9% | -103.6% | +98.9% |
| alltime | all time | -133.7% | +22.9% | -103.6% | +98.9% |
MiNK Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$823.80 K(+22.3%) |
| Jun 2024 | - | -$673.80 K(-86.8%) |
| Mar 2024 | - | -$5.11 M(-34.5%) |
| Dec 2023 | -$7.80 M(-201.1%) | -$7.80 M(+98.9%) |
| Sep 2023 | - | -$3.92 M(+855.4%) |
| Jun 2023 | - | -$410.70 K(-109.6%) |
| Mar 2023 | - | $4.27 M(-44.7%) |
| Dec 2022 | $7.72 M | $7.72 M(+28.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $6.01 M(-53.4%) |
| Jun 2022 | - | $12.90 M(-22.5%) |
| Mar 2022 | - | $16.64 M(-28.2%) |
| Dec 2021 | $23.17 M(-328.8%) | $23.17 M(-130.0%) |
| Sep 2021 | - | -$77.12 M(+21.7%) |
| Jun 2021 | - | -$63.35 M(+525.6%) |
| Dec 2020 | -$10.13 M(+55.8%) | -$10.13 M |
| Dec 2019 | -$6.50 M | - |
FAQ
- What is MiNK Therapeutics annual working capital?
- What is the all time high annual working capital for MiNK Therapeutics?
- What is MiNK Therapeutics annual working capital year-on-year change?
- What is MiNK Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for MiNK Therapeutics?
- What is MiNK Therapeutics quarterly working capital year-on-year change?
What is MiNK Therapeutics annual working capital?
The current annual working capital of INKT is -$7.80 M
What is the all time high annual working capital for MiNK Therapeutics?
MiNK Therapeutics all-time high annual working capital is $23.17 M
What is MiNK Therapeutics annual working capital year-on-year change?
Over the past year, INKT annual working capital has changed by -$15.53 M (-201.07%)
What is MiNK Therapeutics quarterly working capital?
The current quarterly working capital of INKT is -$823.80 K
What is the all time high quarterly working capital for MiNK Therapeutics?
MiNK Therapeutics all-time high quarterly working capital is $23.17 M
What is MiNK Therapeutics quarterly working capital year-on-year change?
Over the past year, INKT quarterly working capital has changed by $0.00 (0.00%)